Clinical Trials Logo

Eye Diseases clinical trials

View clinical trials related to Eye Diseases.

Filter by:

NCT ID: NCT04457648 Completed - Clinical trials for Meibomian Gland Dysfunction

Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease

Start date: June 1, 2018
Phase: Phase 4
Study type: Interventional

Assessor-masked (Single blind, randomized controlled trial comparing the conventional treatment group to an interventional group using 16% Manuka Honey topical eye drops.

NCT ID: NCT04433936 Completed - Keratoconus Clinical Trials

Corneal Tomographic Parameters in TGD

Start date: February 1, 2018
Phase:
Study type: Observational

The current study involved analysis of the corneal tomographic parameters of patients with thyroid gland dysfunction (hyperthyroidism or hypothyroidism), including those with an autoimmune etiology, in comparison to healthy controls without TGD, using pentacam, in an attempt to detect possible early corneal changes and to highlight whether early screening of those patients would be necessary for early detection of KC.

NCT ID: NCT04428541 Recruiting - Eye Diseases Clinical Trials

Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children With Operable Bilateral Ocular Pathologies

EVEIL
Start date: July 16, 2020
Phase: N/A
Study type: Interventional

In some symmetrical pediatric ocular pathologies, the treatment is surgical with usually satisfactory postoperative results in visual terms. However, it is often difficult to choose the right moment to operate. The main difficulty is that the child's vision is unknown since the child is still in a preverbal age. The investigators have developed a questionnaire with the aim of quantifying the child's vision so that the decision is most justified. The items of this questionnaire were established based on the literature and were submitted to a panel of experts in ophthalmo-pediatrics. The objective of this study is to determine the internal validity and as far as possible (since there is no equivalent tool) the external validity of the questionnaire developed.

NCT ID: NCT04426331 Completed - Glaucoma Clinical Trials

Vouchers to Increase Uptake of Already Free Eye Care

Start date: May 5, 2017
Phase: N/A
Study type: Interventional

This study was intended to test if reframing an offer for a free follow-up eye examination could increase uptake within ongoing community-based screening program for low-income and minority populations in Baltimore City. This study evaluated the effect of offering participants a physical voucher they were told was redeemable for free follow-up, relative to simply telling participants that the follow-up appointment would be free of charge. The investigators assessed two forms of vouchers, one with estimated value information, and one without. The underlying hypothesis was that reframing these already free offers would increase uptake by increasing perceived offer value and increasing a sense of regret from not taking advantage of a "good deal."

NCT ID: NCT04425551 Active, not recruiting - Dry Eye Clinical Trials

Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction

Start date: September 5, 2019
Phase: N/A
Study type: Interventional

The modern treatment of meibomian gland dysfunction(MGD) is based on anti-inflammatory drops or oral antibiotics for decreasing dry eye disease (DED) associated inflammation, warm compresses for liquefying the thicker meibum, and lid hygiene for reducing the bacterial overload. But, such treatments have shown limited effectiveness to a large proportion of patients with MGD, due to the multifactorial background of the disease. Thus, alternative approaches aiming at different aspects of the DED pathophysiology are needed. Elimination of posterior lid-margin hyperemia with telangiectasia could be a treatment target for reducing the secretion of inflammatory mediators in the course of MGD. Using the mechanism of photocoagulation via selective thermolysis, laser light could contribute to the destruction of abnormal vessels at the posterior lid-margin and thus, the reduction of inflammation. Recently, sub-threshold (micropulse) laser photocoagulation was introduced in ophthalmology and offers significant clinical advantages compared to conventional continuous wave (CW) approach, preventing laser induced thermal damage and related treatment side effects. This study investigates the effect of sub-threshold (micropulse) laser treatment for dry eye disease due to meibomian gland dysfunction combined with increased eyelid margin vascularity.

NCT ID: NCT04421300 Completed - Dry Eye Clinical Trials

A Randomized Study of Smile Exercise for Dry Eye

Start date: July 2, 2020
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the effectiveness of laughter therapy in relieving the symptoms of dry eye disease.

NCT ID: NCT04416776 Recruiting - Strabismus Clinical Trials

Validation of the Utility of Strabismus Intelligent Diagnostic System

Start date: September 1, 2019
Phase:
Study type: Observational

Strabismus affects approximately 0.8%-6.8% of the world's population and appears by the age of 3 years in 65% of affected individuals. Manual measurement of deviation is often laborious and highly dependent on the experience of the specialist and the cooperation of the patients. Current strabismus evaluation technologies are heavily dependent on model eyes. Here, the investigators use deep learning to develop an artificial intelligence (AI) platform consisting of three deep learning (DL) systems to screen strabismus, evaluate deviation and propose a surgical plan based on corneal light-reflection photos. The investigator also conduct clinical trial to validate its versatility in clinical practice.

NCT ID: NCT04413279 Completed - Dry Eye Syndromes Clinical Trials

Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease

Start date: August 1, 2020
Phase: Phase 4
Study type: Interventional

To evaluate the benefit of treatment with a physician administered intracanalicular dexamethasone insert in evaporative dry eye disease (DED) patients with meibomian gland disfunction (MGD) and underlying inflammation undergoing LipiFlow Thermal Pulsation.

NCT ID: NCT04413253 Terminated - Dry Eye Syndromes Clinical Trials

Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease

Start date: August 1, 2020
Phase: Phase 4
Study type: Interventional

To evaluate the benefit of treatment with a physician administered intracanalicular dexamethasone insert in patients with dry eye who are beginning treatment with Xiidra (lifitegrast ophthalmic solution) to reduce the signs and symptoms of dry eye disease.

NCT ID: NCT04404803 Recruiting - Eye Diseases Clinical Trials

Motivations and Barriers to Participating in Ophthalmology Research Projects

Start date: January 21, 2019
Phase:
Study type: Observational

The primary objective of this project is to understand the reasons why patients agree / disagree to take part in ophthalmology research. This will be done by asking participants to complete a Research Questionnaire.